Financial burden in recipients of allogeneic hematopoietic cell transplantation.

[1]  Sarah T. Hawley,et al.  Long-term financial burden of breast cancer: experiences of a diverse cohort of survivors identified through population-based registries. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  A. Abernethy,et al.  Full disclosure--out-of-pocket costs as side effects. , 2013, The New England journal of medicine.

[3]  V. Arora,et al.  First, do no (financial) harm. , 2013, JAMA.

[4]  E. Coleman,et al.  Personal financial effects of multiple myeloma and its treatment. , 2013, Cancer nursing.

[5]  P. Newcomb,et al.  Washington State cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis. , 2013, Health affairs.

[6]  H. Valdimarsdottir,et al.  Economic survivorship stress is associated with poor health‐related quality of life among distressed survivors of hematopoietic stem cell transplantation , 2013, Psycho-oncology.

[7]  A. Abernethy,et al.  The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience. , 2013, The oncologist.

[8]  Stephanie J. Lee,et al.  Pilot Study of Patient and Caregiver Out-of-Pocket Costs of Allogeneic Hematopoietic Cell Transplantation , 2012, Bone Marrow Transplantation.

[9]  S. Ramsey,et al.  Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer: a population-based exploratory analysis. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  J. Pidala,et al.  Practice variation in physician referral for allogeneic hematopoietic cell transplantation , 2012, Bone Marrow Transplantation.

[11]  S. Bhatia,et al.  Adverse psychological outcomes in long-term survivors of hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study (BMTSS). , 2011, Blood.

[12]  W. Leisenring,et al.  Factors associated with adherence to preventive care practices among hematopoietic cell transplantation survivors. , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[13]  J. Rowland,et al.  Forgoing medical care because of cost , 2010, Cancer.

[14]  Thomas J. Smith,et al.  SPIKE$: a six-step protocol for delivering bad news about the cost of medical care. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  B. Head,et al.  Development and validation of a scale to measure socioeconomic well-being in persons with cancer. , 2008, The journal of supportive oncology.

[16]  T. Beebe,et al.  Agreement between self-reported and administrative race and ethnicity data among Medicaid enrollees in Minnesota. , 2007, Health services research.

[17]  S. Stewart.  140: A survey of hematopoietic cell transplant survivors and spouses: What are the major issues of concern post-transplant? , 2007 .

[18]  John Hsu,et al.  Unintended consequences of caps on Medicare drug benefits. , 2006, The New England journal of medicine.

[19]  P. Ganz.  A teachable moment for oncologists: cancer survivors, 10 million strong and growing! , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  F. Dobbels,et al.  Growing pains: Non‐adherence with the immunosuppressive regimen in adolescent transplant recipients , 2005, Pediatric transplantation.

[21]  C. Bennett,et al.  Lack of caregivers limits use of outpatient hematopoietic stem cell transplant program , 2002, Bone Marrow Transplantation.

[22]  E. Bass,et al.  Outpatient-based bone marrow transplantation for hematologic malignancies: cost saving or cost shifting? , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  J. Ware,et al.  A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. , 1996, Medical care.

[24]  W. Feng,et al.  Treatment Interruptions and Non-Adherence with Imatinib and Associated Healthcare Costs , 2012, PharmacoEconomics.

[25]  Wenke Hwang,et al.  Rising out-of-pocket spending for chronic conditions: a ten-year trend. , 2009, Health affairs.

[26]  T. Beebe,et al.  Validating Health Insurance Coverage Survey Estimates A Comparison of Self-Reported Coverage and Administrative Data Records , 2008 .

[27]  Michael Halpern,et al.  Association of Insurance with Cancer Care Utilization and Outcomes , 2008, CA: a cancer journal for clinicians.